
Study investigator David Berg explains why volume overload shouldn't decide which hospitalized patients get an SGLT2 inhibitor.
Pat Basu, MD, MBA, chief medical officer of Doctor on Demand, discusses legislative issues and technology that could affect pharmacy.
Pat Basu, MD, MBA, chief medical officer of Doctor on Demand, discusses legislative issues and technology that could affect pharmacy.
This video was recorded at the 2015 NACDS Total Store Expo.






